Zepatier
Drug timelines are a Plus or Pro feature.
19 regulatory and trial events tracked for Zepatier, covering 2016-01-28 to 2025-11-07. Get the full timeline:
Most recent: EMA Authorised: Zepatier (elbasvir;grazoprevir) — Merck Sharp & Dohme B.V.